tiprankstipranks
Trending News
More News >
Seelos Therapeutics, Inc. (DE:NXE)
:NXE
Germany Market
Advertisement

Seelos Therapeutics (NXE) Cash flow

Compare
2 Followers

Seelos Therapeutics Cash Flow

DE:NXE's free cash flow for Q2 2023 was $-5.90M. For the 2023 fiscal year, DE:NXE's free cash flow was decreased by $-12.61M and operating cash flow was $-5.90M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -61.60M$ -48.99M$ -20.91M$ -19.30M$ -8.13M
Investing Cash Flow
$ ―$ ―$ ―$ ―$ ―
Financing Cash Flow
$ ―$ ―$ ―$ ―$ ―
End Cash Position
$ ―$ ―$ ―$ ―$ ―
Free Cash Flow
$ -61.60M$ -48.99M$ -20.91M$ -19.30M$ -8.13M
Currency in USD

Seelos Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis